You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for NDC 82009-0012


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 82009-0012

Drug NameNDCPrice/Unit ($)UnitDate
SIMVASTATIN 5 MG TABLET 82009-0012-10 0.04102 EACH 2025-03-19
SIMVASTATIN 5 MG TABLET 82009-0012-10 0.04037 EACH 2025-02-19
SIMVASTATIN 5 MG TABLET 82009-0012-10 0.03492 EACH 2025-01-22
SIMVASTATIN 5 MG TABLET 82009-0012-10 0.03346 EACH 2024-12-18
SIMVASTATIN 5 MG TABLET 82009-0012-10 0.02988 EACH 2024-11-20
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 82009-0012

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Drug NDC: 82009-0012

Understanding the National Drug Code (NDC)

To analyze the market and project prices for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug. For the NDC 82009-0012, each segment provides specific information:

  • Labeler Code: The first segment (82009) is assigned by the FDA and identifies the firm that manufactures, repackages, or relabels the drug.
  • Product Code: The second segment (001) identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment (2) identifies the package size and type[1][4].

Market Trends in Prescription Drugs

The prescription drug market is experiencing significant trends that impact pricing and availability.

Price Inflation

The overall prescription drug market is projected to see a 3.8% price increase, driven largely by specialty pharmaceuticals. This includes drugs for complex or chronic conditions such as cancer, infectious diseases, autoimmune diseases, and pulmonary conditions. Specialty pharmaceuticals, which are a major contributor to this increase, are expected to see a 4.18% price rise in 2024[2].

Global Price Comparisons

Prices for prescription drugs in the U.S. are notably higher than in other regions. By 2022, prices in the U.S. were 5.5 times those in the OECD (excluding the U.S.) and 7.7 times prices in the rest of the world (excluding the U.S.). This disparity is partly due to the U.S. having a drug mix that skews towards more expensive compounds[3].

Frequency and Timing of Price Increases

Price increases for prescription drugs tend to occur predominantly in January and July each year. In 2022, the average price increase in January was nearly $150 per drug (10.0% increase), and in July, it was $250 (7.8% increase). These increases are often significant, with some drugs experiencing price hikes of over $20,000 or more than 500%[5].

Specific Analysis for NDC 82009-0012

To project prices for the drug with NDC 82009-0012, we need to consider several factors:

Current Pricing

The current price of the drug can be found in the FDA's National Drug Code Directory or through other pharmaceutical databases. However, specific pricing details are not provided in the sources, so we would need to consult the latest listings or contact the labeler directly.

Category and Usage

Understanding whether the drug falls under the category of specialty pharmaceuticals or is used for chronic conditions can help in predicting future price trends. Specialty drugs, in particular, are expected to see higher price increases due to their complex nature and high demand[2].

Historical Price Changes

Analyzing historical price changes for this specific NDC can provide insights into future price projections. If the drug has experienced significant price increases in the past, especially during the typical January and July periods, it is likely to continue this trend[5].

Regulatory and Market Factors

Changes in regulatory requirements, market demand, and the introduction of new drugs can also impact pricing. For instance, if the drug is part of a competitive market with multiple alternatives, price increases might be more modest compared to drugs with limited competition.

Price Projections

Given the general trends in the prescription drug market:

  • Short-Term Projections: For 2024, a price increase of around 4-5% could be expected, aligning with the overall trend for specialty and non-specialty drugs.
  • Long-Term Projections: Over the next few years, if the drug remains in high demand and is part of the specialty pharmaceutical category, it could see higher price increases, potentially exceeding the average market rate.

Key Considerations

  • Supply Chain and Distribution: Any disruptions in the supply chain or changes in distribution strategies can impact pricing.
  • Competitive Landscape: The presence of generic or biosimilar alternatives can influence pricing decisions.
  • Regulatory Changes: Updates in FDA regulations or changes in the Drug Listing Act could affect how drugs are listed and priced.

Example Scenario

If the drug with NDC 82009-0012 is a specialty pharmaceutical used for treating a chronic condition, here is a possible scenario:

  • Current Price: Assume the current price is $100 per unit.
  • Projected Increase: Based on the 4.18% increase for specialty drugs, the price could rise to $104.18 by the end of 2024.
  • Long-Term: Over the next 5 years, if the drug continues to be in high demand and faces limited competition, it could see cumulative price increases of 20-25%, bringing the price to around $125-130 per unit.

Conclusion

The market analysis and price projections for the drug with NDC 82009-0012 depend on various factors including its category, historical price changes, and broader market trends. Understanding these elements is crucial for accurate price forecasting.

Key Takeaways

  • NDC Understanding: The NDC is a unique identifier that helps in tracking and analyzing drug products.
  • Market Trends: Specialty pharmaceuticals are driving price increases, with a projected 4.18% rise in 2024.
  • Global Price Disparities: U.S. drug prices are significantly higher than in other regions.
  • Price Increase Timing: Most price increases occur in January and July.
  • Regulatory and Market Factors: Changes in regulations and market conditions can impact pricing.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug.

Why are drug prices in the U.S. higher than in other countries?

Drug prices in the U.S. are higher due to a mix of more expensive compounds and different pricing mechanisms compared to other regions.

When do most prescription drug price increases occur?

Most prescription drug price increases occur in January and July each year.

What factors influence the price of a specific drug?

Factors such as the drug's category, historical price changes, regulatory requirements, and market demand influence the price of a specific drug.

How can one find the current price of a drug with a specific NDC?

The current price can be found in the FDA's National Drug Code Directory or through other pharmaceutical databases.

Sources

  1. FDA: National Drug Code Database Background Information - FDA
  2. Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
  3. ASPE: International Market Size and Prices
  4. FDA: National Drug Code Directory - FDA
  5. ASPE: Price Increases for Prescription Drugs, 2016-2022

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.